Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Iftikhar Ahmed, Zafar Niaz, Frederick Ewbank, Danyal Akarca, Richard Felwick & Manuele Furnari. (2018) Sniffing Out Causes of Gastrointestinal Disorders: A Review of Volatile Metabolomic Biomarkers. Biomarkers in Medicine 12:10, pages 1139-1148.
Read now
Read now
Articles from other publishers (25)
Aryamitra Banerjee & Ramesh C. Gupta. 2019. Biomarkers in Toxicology. Biomarkers in Toxicology
277
285
.
Eric L Campbell & Sean P Colgan. (2015) Neutrophils and inflammatory metabolism in antimicrobial functions of the mucosa. Journal of Leukocyte Biology 98:4, pages 517-522.
Crossref
Crossref
Aryamitra Banerjee. 2014. Biomarkers in Toxicology. Biomarkers in Toxicology
269
277
.
Bincy P. Abraham & Sunanda Kane. (2012) Fecal Markers: Calprotectin and Lactoferrin. Gastroenterology Clinics of North America 41:2, pages 483-495.
Crossref
Crossref
Ibrahim Masoodi, Rakesh Kochhar, Usha Dutta, Chetana Vaishnavi, K. K. Prasad, Kim Vaiphei, Shabnum Hussain & Kartar Singh. (2012) Evaluation of Fecal Myeloperoxidase as a Biomarker of Disease Activity and Severity in Ulcerative Colitis. Digestive Diseases and Sciences 57:5, pages 1336-1340.
Crossref
Crossref
Heba N. Iskandar & Matthew A. Ciorba. (2012) Biomarkers in inflammatory bowel disease: current practices and recent advances. Translational Research 159:4, pages 313-325.
Crossref
Crossref
Rachel J. Gibson & Joanne M. Bowen. (2011) Biomarkers of regimen-related mucosal injury. Cancer Treatment Reviews 37:6, pages 487-493.
Crossref
Crossref
Kaarina Kukkonen, Mikael Kuitunen, Tari Haahtela, Riitta Korpela, Tuija Poussa & Erkki Savilahti. (2010) High intestinal IgA associates with reduced risk of IgE‐associated allergic diseases. Pediatric Allergy and Immunology 21:1-Part-I, pages 67-73.
Crossref
Crossref
Ibrahim Masoodi, Rakesh Kochhar, Usha Dutta, Chetana Vaishnavi, Kaushal K Prasad, Kim Vaiphei, Sukhminder Kaur & Kartar Singh. (2009) Fecal lactoferrin, myeloperoxidase and serum C‐reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis. Journal of Gastroenterology and Hepatology 24:11, pages 1768-1774.
Crossref
Crossref
Javier P. Gisbert, Adrian G. McNicholl & Fernando Gomollon. (2009) Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease. Inflammatory Bowel Diseases 15:11, pages 1746-1754.
Crossref
Crossref
Bincy P. Abraham & Selvi Thirumurthi. (2009) Clinical significance of inflammatory markers. Current Gastroenterology Reports 11:5, pages 360-367.
Crossref
Crossref
Javier P. Gisbert, Fernando Bermejo, Jose-Lázaro Pérez-Calle, Carlos Taxonera, Isabel Vera, Adrian G. McNicholl, Alicia Algaba, Pilar López, Natalia López-Palacios, Marta Calvo, Yago González-Lama, Jose-Antonio Carneros, Marta Velasco & José Maté. (2009) Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflammatory Bowel Diseases 15:8, pages 1190-1198.
Crossref
Crossref
J.P. Gisbert & A.G. McNicholl. (2009) Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Digestive and Liver Disease 41:1, pages 56-66.
Crossref
Crossref
S.P. VORAVUTHIKUNCHAI, K. OKADA, T. IIDA & T. HONDA. (2008) EARLY DIAGNOSIS OF INFECTIOUS DIARRHEA USING LACTOFERRIN AND HEMOGLOBIN MARKERS. Journal of Rapid Methods & Automation in Microbiology 16:4, pages 288-298.
Crossref
Crossref
Andrew D. Sutherland, Richard B. Gearry & Frank A. Frizelle. (2008) Review of Fecal Biomarkers in Inflammatory Bowel Disease. Diseases of the Colon & Rectum 51:8, pages 1283-1291.
Crossref
Crossref
Imerio Angriman, Marco Scarpa, Renata D'Incà, Daniela Basso, Cesare Ruffolo, Lino Polese, Giacomo C. Sturniolo, Davide F. D'Amico & Mario Plebani. (2007) Enzymes in feces: Useful markers of chronic inflammatory bowel disease. Clinica Chimica Acta 381:1, pages 63-68.
Crossref
Crossref
Javier P. Gisbert, Yago González-Lama & José Maté. (2007) Papel de los marcadores biológicos en la enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 30:3, pages 117-129.
Crossref
Crossref
D. DESAI, W. A. FAUBION & W. J. SANDBORN. (2007) Review article: biological activity markers in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 25:3, pages 247-255.
Crossref
Crossref
R. B. Gearry. 2007. Emerging Issues in Inflammatory Bowel Diseases. Emerging Issues in Inflammatory Bowel Diseases
135
148
.
Paul A Rufo & Athos Bousvaros. (2006) Current Therapy of Inflammatory Bowel Disease in Children. Pediatric Drugs 8:5, pages 279-302.
Crossref
Crossref
Timothy A. Sentongo & David M. Steinhorn. 2006. Pediatric Critical Care. Pediatric Critical Care
1227
1242
.
Barbara Lisowska-Myjak. (2005) AAT as a diagnostic tool. Clinica Chimica Acta 352:1-2, pages 1-13.
Crossref
Crossref
Taina Arvola, Eeva Moilanen, Risto Vuento & Erika Isolauri. (2004) Weaning to Hypoallergenic Formula Improves Gut Barrier Function in Breast-Fed Infants With Atopic Eczema. Journal of Pediatric Gastroenterology and Nutrition 38:1, pages 92-96.
Crossref
Crossref
Taina Arvola, Eeva Moilanen, Risto Vuento & Erika Isolauri. (2004) Weaning to Hypoallergenic Formula Improves Gut Barrier Function in Breast‐Fed Infants With Atopic Eczema. Journal of Pediatric Gastroenterology and Nutrition 38:1, pages 92-96.
Crossref
Crossref
Matthieu Allez & Robert Modigliani. (2000) Clinical features of inflammatory bowel disease. Current Opinion in Gastroenterology 16:4, pages 329-336.
Crossref
Crossref